Ablynx Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 438

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $4.72B

Ablynx General Information

Description

Manufacturer of biopharmaceutical products created to offer proteins based therapeutics for treatment of inflammation, hematology, immuno-oncology, oncology and respiratory diseases. The company's biopharmaceutical products comprises of their patented product named, Nanobodies that is a therapeutic proteins based on single-chain antibody fragments that combine the benefits of drugs based on conventional antibodies and small chemical molecules, enabling patients avail various therapeutic and new drugs that can make a clear difference to society.

Contact Information

Website
www.ablynx.com
Formerly Known As
MatchX
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Technologiepark 21
  • 9052 Ghent
  • Belgium
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Sanofi
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • Technologiepark 21
  • 9052 Ghent
  • Belgium

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ablynx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 14-May-2018 $4.72B Completed Profitable
13. Merger/Acquisition 01-Dec-2017 Cancelled Profitable
12. 2PO 25-Oct-2017 Completed Profitable
11. PIPE 04-Oct-2017 Completed Profitable
10. Secondary Transaction - Open Market 03-Nov-2016 Completed Profitable
9. PIPE 01-Jun-2016 Completed Profitable
8. Secondary Transaction - Open Market 18-Oct-2013 Completed Generating Revenue
7. 2PO 16-Mar-2010 Completed Generating Revenue
6. IPO 07-Nov-2007 $108M $196M Completed Generating Revenue
5. Later Stage VC (Series C) 23-Aug-2006 $51.2M $88.2M Completed Generating Revenue
To view Ablynx’s complete valuation and funding history, request access »

Ablynx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of biopharmaceutical products created to offer proteins based therapeutics for treatment of inflammation, h
Biotechnology
Ghent, Belgium
438 As of 2017

Pittsburgh, PA
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ablynx Competitors (76)

One of Ablynx’s 76 competitors is Krystal Biotech, a Formerly VC-backed company based in Pittsburgh, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Krystal Biotech Formerly VC-backed Pittsburgh, PA
Arrowhead Pharmaceuticals Corporation Pasadena, CA
Abeona Therapeutics Corporation Cleveland, OH
Adaptimmune Therapeutics Formerly VC-backed Abingdon, United Kingdom
vTv Therapeutics Formerly PE-Backed High Point, NC
You’re viewing 5 of 76 competitors. Get the full list »

Ablynx Patents

  • 1,338

    Total Documents Applications and Grants

  • Total Patents Families

  • 779

    Granted

  • 191

    Pending

  • Expiring in next 12 mo

Ablynx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250154262-A1 Fc domain variants with enhanced fc receptor binding Pending 25-Oct-2023
US-20240209107-A1 Cd28/ox40 bispecific antibodies Active 10-Oct-2023
US-12195546-B2 Cd28/ox40 bispecific antibodies Active 10-Oct-2023
US-20250129145-A1 Bi- and multivalent albumin binders Pending 22-Sep-2023
US-20240368250-A1 Polypeptides binding to the neonatal fc receptor Pending 17-Feb-2023 C07K14/765
To view Ablynx’s complete patent history, request access »

Ablynx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ablynx Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Alta Partners Venture Capital Minority
Fidelity Management & Research Company Asset Manager Minority
Gilde Healthcare Venture Capital Minority
Gimv PE/Buyout Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Ablynx ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Ablynx’s complete esg history, request access »

Ablynx FAQs

  • When was Ablynx founded?

    Ablynx was founded in 2001.

  • Where is Ablynx headquartered?

    Ablynx is headquartered in Ghent, Belgium.

  • What is the size of Ablynx?

    Ablynx has 438 total employees.

  • What industry is Ablynx in?

    Ablynx’s primary industry is Biotechnology.

  • Is Ablynx a private or public company?

    Ablynx is a Private company.

  • What is the current valuation of Ablynx?

    The current valuation of Ablynx is .

  • What is Ablynx’s current revenue?

    The current revenue for Ablynx is .

  • How much funding has Ablynx raised over time?

    Ablynx has raised $578M.

  • Who are Ablynx’s investors?

    Abingworth, Alta Partners, Fidelity Management & Research Company, Gilde Healthcare, and Gimv are 5 of 10 investors who have invested in Ablynx.

  • Who are Ablynx’s competitors?

    Krystal Biotech, Arrowhead Pharmaceuticals, Abeona Therapeutics, Adaptimmune Therapeutics, and vTv Therapeutics are some of the 76 competitors of Ablynx.

  • When was Ablynx acquired?

    Ablynx was acquired on 14-May-2018.

  • Who acquired Ablynx?

    Ablynx was acquired by Sanofi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »